Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study.
Journal: The Lancet. Neurology
Published: August 20, 2024
Optimizing bevacizumab dosing in glioblastoma: less is more.
Journal: Journal of neuro-oncology
Published: January 29, 2017
Showing 1-2 of 2
Last Updated: 09/26/2026